首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   255篇
  免费   35篇
  国内免费   9篇
耳鼻咽喉   3篇
儿科学   3篇
妇产科学   5篇
基础医学   51篇
口腔科学   1篇
临床医学   5篇
内科学   36篇
皮肤病学   1篇
神经病学   35篇
特种医学   69篇
外科学   25篇
综合类   8篇
预防医学   16篇
眼科学   3篇
药学   13篇
肿瘤学   25篇
  2023年   6篇
  2022年   4篇
  2021年   13篇
  2020年   16篇
  2019年   40篇
  2018年   19篇
  2017年   14篇
  2016年   10篇
  2015年   16篇
  2014年   15篇
  2013年   14篇
  2012年   8篇
  2011年   15篇
  2010年   8篇
  2009年   2篇
  2008年   13篇
  2007年   5篇
  2006年   15篇
  2005年   5篇
  2004年   4篇
  2003年   5篇
  2002年   2篇
  2001年   5篇
  2000年   4篇
  1999年   4篇
  1998年   5篇
  1997年   5篇
  1996年   1篇
  1994年   1篇
  1990年   3篇
  1987年   2篇
  1986年   1篇
  1985年   6篇
  1984年   1篇
  1983年   4篇
  1982年   2篇
  1981年   2篇
  1980年   2篇
  1978年   1篇
  1977年   1篇
排序方式: 共有299条查询结果,搜索用时 15 毫秒
61.
MRI of hyperpolarized 129Xe dissolved in pulmonary tissues, and blood has the potential to offer a new tool for regional evaluation of pulmonary gas exchange and perfusion; however, the extremely short T and low magnetization density make it difficult to acquire the image. In this study, an ultrashort echo‐time sequence was introduced, and its feasibility to quantitatively assess emphysema‐like pulmonary tissue destruction by a combination of dissolved‐ and gas‐phase 129Xe lung MRI was investigated. The ultrashort echo‐time has made it possible to acquire dissolved 129Xe images with reasonably high spatial resolution of 0.625 × 0.625 mm2 and to obtain T of 0.67 ± 0.30 ms in a spontaneously breathing mouse at 9.4 T. The regional dynamic alveolar gas uptake as well as subsequent transport by pulmonary blood flow was also visualized. The ratio of 129Xe magnetization that diffused into the septa relative to the gas‐phase magnetization F was regionally evaluated. The mean F value of elastase‐treated mice was 2.28 ± 0.46%, which was significantly reduced from that of control mice 3.41 ± 0.48% (P = 0.0052). This reflects the reduced uptake efficiency due to alveolar tissue destruction and is correlated with the histologically derived alveolar surface‐to‐volume ratio. Magn Reson Med, 2013. © 2012 Wiley Periodicals, Inc.  相似文献   
62.
63.
Review of 2895 consecutive autopsies from 1962 to 1980 inclusive showed no significant differences in the prevalence of emphysema or other chronic lung disease between 282 active and retired employees of a cotton textile mill and the nontextile population. There was no statistical evidence that exposure to cotton dust, even after many years, produced emphysema, interstitial fibrosis, or cor pulmonale. The prevalence of emphysema in the series was highest in white males (22.0%), followed closely by black males (18.3%). In white females it was 7.5%, in black females, 5.5%. The prevalence in subjects under age 50 yr was 4.5%; in the age group 60-64 yr, 14.6%; and in subjects 65 yr of age and older, 21.9%. A significant increase in the prevalence of emphysema occurred between the 1962 to 1969 period and the 1970 to 1980 period.  相似文献   
64.
65.
131I is one of the most important radionuclides used in nuclear medicine. The accompanying isotope 129I with insignificant activities in 131I-pharmaceuticals, produced in THOR, were determined in terms of 129I/131I ratio by neutron activation analysis. The detection limit of 129I can be lowered to order of 0.1 Bq, superior to conventional radiometric methods. The 129I/131I ratios in the 131I-pharmaceuticals, were measured to be in the range from 3.9 to 8.3.  相似文献   
66.
67.

Introduction

In this phase 2 study, we evaluated the activity of AUY922 in pretreated patients with stage IV NSCLC.

Methods

Patients with advanced NSCLC were divided into molecularly defined strata based on mutations in the EGFR gene, the ALK receptor tyrosine kinase gene (ALK), the KRAS gene, or the wild type of all three. All patients must have received more than two prior lines of therapy, except for those in a fifth stratum for a less pretreated EGFR cohort (EGFR<2). In the EGFR-mutant and ALK-rearranged strata, prior platinum therapy was not required. Patients with EGFR mutation must have received an EGFR tyrosine kinase inhibitor unless they had de novo resistance (e.g., T790M or exon 20 insertions). Eligible patients received weekly intravenous AUY922, 70 mg/m2. The primary objective was to estimate efficacy (complete or partial response, or in the absence of complete or partial response, stable disease) at 18 weeks, by the Response Criteria in Solid Tumors.

Results

A total of 153 patients from 21 global centers were enrolled from October 2010 to November 2014. The investigator-assessed overall response rate and stable disease rate at 18 weeks were 31.8% and 9.1% in the ALK-rearranged stratum, 17.1% and 8.6% in EGFR-mutant stratum, 9.7% and 22.6% in the EGFR<2 stratum, 0% and 7.1% in KRAS-mutant stratum, and 8.8% and 8.8% in wild-type stratum. Biomarker data showed activity of AUY922 in EGFR-mutant patients with exon 19 deletion, T790M mutation, and exon 20 insertion. The most common (≥40%) all-causality adverse events were diarrhea, nausea, and decreased appetite. Visual-related disorders were reported in 79.7% of patients (most were grade 1/2). Thirty-five patients (22.9%) reported night blindness.

Conclusion

AUY922 is active in patients with NSCLC, particularly among patients with ALK rearrangements and EGFR mutations.  相似文献   
68.
69.
70.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号